Zhong, B., Xu, X. (2025). Transarterial chemoembolization plus donafenib and immune checkpoint inhibitors for intermediate hepatocellular carcinoma (CHANCE2410): A propensity score matching analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4126